Literature DB >> 30324116

Induction of Specific Humoral Immune Response in Mice against a Pseudomonas aeruginosa Chimeric PilQ/PilA Protein.

Mehrdad Gholami1, Alireza Salimi Chirani2, Reza Falak3, Mona Moshiri4, Shabnam Razavi1,5, Gholamreza Irajian1,5.   

Abstract

BACKGROUND: Pseudomonas aeruginosa, an opportunistic pathogen, is a common cause of healthcare-associated infections in immunocompromised individuals. The rapid emergence of multidrug-resistant strains has made P. aeruginosa infections progressively difficult to treat. In this study we evaluated the effect of a chimeric protein containing a P. aeruginosa PilQ fragment and the PilA disulfide loop (PilA-DSL) on the humoral immune response in BALB/c mice.
METHODS: A chimeric gene encoding an immunogenic region of PilQ and the PilA-DSL was synthesized. Following bacterial expression and purification, the protein was administered to mice and the humoral immune response analyzed. The resulting antibodies were analyzed using an opsonophagocytic killing assay.
RESULTS: The anti-recombinant protein antibody titer was significantly greater in immunized mice than in controls. In addition, antibody titers were significantly increased after booster immunizations, and the immunizations induced opsonophagocytosis of P. aeruginosa PAO1.
CONCLUSION: These results suggest that an anti-adhesion-based vaccination may be effective in preventing P. aeruginosa infections. Further studies are needed to evaluate the abilities of such bivalent proteins to induce strong immune responses.

Entities:  

Keywords:  Chimeric protein; PilQ; Pseudomonas aeruginosa; Type IV pili; Vaccine

Year:  2018        PMID: 30324116      PMCID: PMC6175586     

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  26 in total

Review 1.  Bacterial adhesins in host-microbe interactions.

Authors:  Kimberly A Kline; Stefan Fälker; Sofia Dahlberg; Staffan Normark; Birgitta Henriques-Normark
Journal:  Cell Host Microbe       Date:  2009-06-18       Impact factor: 21.023

2.  Decellularized human amniotic membrane: more is needed for an efficient dressing for protection of burns against antibiotic-resistant bacteria isolated from burn patients.

Authors:  M Gholipourmalekabadi; M Bandehpour; M Mozafari; A Hashemi; H Ghanbarian; M Sameni; M Salimi; M Gholami; A Samadikuchaksaraei
Journal:  Burns       Date:  2015-06-03       Impact factor: 2.744

3.  Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria.

Authors:  E T Yin; C Galanos; S Kinsky; R A Bradshaw; S Wessler; O Lüderitz; M E Sarmiento
Journal:  Biochim Biophys Acta       Date:  1972-01-28

4.  In silico analysis and modeling of ACP-MIP-PilQ chimeric antigen from Neisseria meningitidis serogroup B.

Authors:  Mehrdad Gholami; Alireza Salimi Chirani; Mona Moshiri; Mansour Sedighi; Abazar Pournajaf; Masoud Tohidfar; Gholamreza Irajian
Journal:  Rep Biochem Mol Biol       Date:  2015-10

5.  In silico analysis and molecular modeling of RNA polymerase, sigma S (RpoS) protein in Pseudomonas aeruginosa PAO1.

Authors:  Mansour Sedighi; Mohsen Moghoofei; Ebrahim Kouhsari; Abazar Pournajaf; Behzad Emadi; Masoud Tohidfar; Mehrdad Gholami
Journal:  Rep Biochem Mol Biol       Date:  2015-10

6.  Comparison of type IV-pilin genes of Pseudomonas aeruginosa of various habitats has uncovered a novel unusual sequence.

Authors:  C Spangenberg; R Fislage; W Sierralta; B Tümmler; U Römling
Journal:  FEMS Microbiol Lett       Date:  1995-01-15       Impact factor: 2.742

7.  Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses.

Authors:  P A Castric; C D Deal
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.

Authors:  Joseph Horzempa; Thomas K Held; Alan S Cross; Dana Furst; Mohammed Qutyan; Alice N Neely; Peter Castric
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

9.  Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.

Authors:  P Ames; D DesJardins; G B Pier
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

10.  Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.

Authors:  Lucia Peluso; Cristiana de Luca; Silvia Bozza; Antonio Leonardi; Gloria Giovannini; Alfonso Lavorgna; Gaetano De Rosa; Massimo Mascolo; Loredana Ortega De Luna; Maria Rosaria Catania; Luigina Romani; Fabio Rossano
Journal:  BMC Microbiol       Date:  2010-01-13       Impact factor: 3.605

View more
  2 in total

Review 1.  Emerging therapies against infections with Pseudomonas aeruginosa.

Authors:  Burkhard Tümmler
Journal:  F1000Res       Date:  2019-08-07

Review 2.  Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Authors:  Maite Sainz-Mejías; Irene Jurado-Martín; Siobhán McClean
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.